Elizabeth McFarland, MD

Medical Director, Children's Hospital Colorado HIV Program
Medical Director, Pediatric Infectious Disease Outpatient Clinic
Professor of Pediatrics
Section Chief, Pediatric Infectious Diseases

Provider's Specialties

Infectious Disease - Pediatric
Pediatrics

Provider's location(s)

Anschutz Medical Campus, Aurora

View map

Patient ratings

Patient ratings and reviews are not available

Why?

Pediatric Infectious Disease Program

(720)777-6981

Insurance plans accepted

We participate with most major health insurance plans and national transplant networks.

View the full list

Prepare for your visit

We want to make sure you know what to expect before you arrive.

See the checklist

Get to know Elizabeth McFarland, MD

Departments and Programs

Infectious Disease

Conditions Treated

AIDS
HIV Disease
Immunization
Viral Infections

Pneumonia
Influenza - Seasonal
Fungal Infections
Bacterial Infections
Fever

Languages spoken

English

Experience and background

I am interested in pediatric infectious diseases, particularly pediatric and perinatal HIV Infection.

Undergraduate 1981

Northwestern University (IL)

Medical Education 1985

Duke University School of Medicine

Internship 1986

University of Colorado (University Hospital) Program

Residency 1988

University of Colorado (University Hospital) Program

Fellowship 1992

University of Colorado (University Hospital) Program

For Patients:
I am studying the maturation of cell-mediated immune responses in both normal and HIV-infected infants, immune responses to HIV vaccines in exposed newborns, the role of cytotoxic T-lymphocytes in the pathogenesis of congenitally acquired HIV infection, pediatric HIV clinical trials of antiretroviral therapy and vaccines, and complications of HIV and treatment. I develop immunology and immune-based therapy research for the National Institutes of Health Pediatric AIDS Clinical Trials Group and have chaired several of their subcommittees, including the Pediatric Immunology Core Laboratory Committee and the Pediatric Cytotoxic T-lymphocyte Working Group. I am a frequently invited speaker at local, national, and international events.

For Referring Providers:
Dr. McFarland is studying the maturation of cell-mediated immune responses in both normal and HIV-infected infants, immune responses to HIV vaccines in exposed newborns, the role of cytotoxic T-lymphocytes in the pathogenesis of congenitally acquired HIV infection, pediatric HIV clinical trials of antiretroviral therapy and vaccines, and complications of HIV and treatment. Dr. McFarland develops immunology and immune-based therapy research for the National Institutes of Health Pediatric AIDS Clinical Trials Group and has chaired several of their subcommittees, including the Pediatric Immunology Core Laboratory Committee and the Pediatric Cytotoxic T-lymphocyte Working Group. She is a frequently invited speaker at local, national, and international events.